Biobot Analytics GTM brain

Biobot sells wastewater-based population health intelligence to government agencies and pharmaceutical and life sciences organizations.

category

Wastewater epidemiology intelligence

market profile

  • text: Public health agencies need early population-level signals for infectious disease and substance use response.
  • text: Commercial life sciences teams can use geographic disease trends to plan trials and campaigns.

personas

  • title: State epidemiologist or public health surveillance director
    pains:
    • Clinical reports can lag emerging outbreaks
    • Must allocate limited response resources across communities
  • title: Pharma epidemiology or clinical trial operations leader
    pains:
    • Disease incidence changes across trial sites
    • Campaign planning needs timely local population signals
  • title: Federal biodefense program manager
    pains:
    • Needs early warning across jurisdictions
    • Must evaluate many pathogens with limited surveillance capacity

icp

  • text: Federal, state and local government health agencies responsible for disease surveillance or substance use programs.
  • text: Vaccine manufacturers and life sciences companies running geographically distributed trials or public health campaigns.
  • text: Health systems and wastewater treatment organizations seeking population-level community health intelligence.

message pillars

  • text: Use predictive wastewater signals to see emerging trends earlier.
  • text: Monitor a broad range of pathogens and substances with one data source.
  • text: Turn national coverage into local action.
  • text: Connect disease intelligence to commercial trial planning.

objections

  • objection: Can wastewater data support action without individual diagnoses?
    response: Position it as a complementary population-level early signal alongside clinical surveillance, and review relevant validation and use cases.
  • objection: Will the budget sustain recurring surveillance?
    response: Scope target pathogens, locations and decision use cases, then compare costs against the value of earlier response.

competitors

  • name: Verily
    why: Provides wastewater surveillance and holds the CDC national testing contract.
  • name: Kando
    why: Offers wastewater intelligence and analytics.
  • name: Eurofins Scientific
    why: Competes in wastewater testing and surveillance services.

influencers

  • name: Mariana Matus
    url: https://www.ycombinator.com/founders/mariana-matus
    why: Biobot cofounder and CEO; prominent wastewater epidemiology voice.

keywords

  • wastewater epidemiology
  • wastewater disease surveillance
  • pathogen monitoring wastewater
  • wastewater opioid surveillance
  • infectious disease early warning
  • clinical trial site disease intelligence

voice

  • scientific
  • forward-looking
  • public-health oriented

signals

  • text: Agency issues a wastewater surveillance procurement or expands pathogen monitoring.
  • text: Vaccine manufacturer expands geographically distributed clinical trials or disease forecasting.

pricing

model: unknown

motion

sales_led

channels

  • SEO
  • press
  • LinkedIn
  • X

confidence

high

Founders

  • name: Newsha Ghaeli
    title: Founder/President
    role: Founder
  • name: Mariana Matus
    title: Founder
    role: Founder

Back to YC companies